MoneyWorks4Me

Par Drugs & Chem. - Quaterly Results

16 Feb 2024 Evaluate
The quarter ended December 2023 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 239.99 millions.Profit for the quarter ended December 2023 rises by 83.24% to Rs. 34.21  millions from Rs. 18.67 millions.Operating profit for the quarter ended December 2023 rose to 54.57 millions as compared to 32.68 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 239.99 229.33 4.65 728.21 712.57 2.19 957.49 750.74 27.54
Other Income 2.29 0.38 502.63 2.90 2.07 40.10 2.38 1.84 29.35
PBIDT 54.57 32.68 66.98 170.13 130.30 30.57 184.46 164.39 12.21
Interest 0.20 0.30 -33.33 0.63 1.07 -41.12 1.33 4.54 -70.70
PBDT 54.37 32.38 67.91 169.50 129.23 31.16 183.13 159.85 14.56
Depreciation 8.65 7.43 16.42 25.44 23.86 6.62 32.33 32.81 -1.46
PBT 45.72 24.95 83.25 144.06 105.37 36.72 150.80 127.04 18.70
TAX 11.51 6.28 83.28 36.25 26.52 36.69 37.45 34.90 7.31
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.50 1.45 -134.48
PAT 34.21 18.67 83.24 107.81 78.85 36.73 113.35 92.14 23.02
Equity 123.05 123.05 0.00 123.05 123.05 0.00 123.05 123.05 0.00
PBIDTM(%) 22.74 14.25 59.57 23.36 18.29 27.76 19.26 21.90 -12.02
Peers
Company Name CMP
Sun Pharma. Inds. 1874.00
Dr. Reddys Labs. 1192.40
Cipla 1384.60
Lupin 2106.95
Zydus Lifesciences 1166.05
View more..